Heterogeneous metabolic response of endothelial cells from different vascular beds to experimental hyperglycaemia and metformin (original) (raw)

McAleese, C. ORCID logoORCID: https://orcid.org/0000-0003-2756-4941, Joudah, G., Salt, I.P. ORCID logoORCID: https://orcid.org/0000-0003-0055-3724, Petrie, J.R. ORCID logoORCID: https://orcid.org/0000-0002-4894-9819, Leiper, J.M. ORCID logoORCID: https://orcid.org/0000-0003-4656-519X and Dowsett, Laura B. ORCID logoORCID: https://orcid.org/0000-0002-3356-8183(2025) Heterogeneous metabolic response of endothelial cells from different vascular beds to experimental hyperglycaemia and metformin.Journal of Physiology, (doi: 10.1113/JP288006) (PMID:39998029) (Early Online Publication)

Abstract

Endothelial cells (ECs) are highly glycolytic, with mitochondria primarily serving a signalling function. Metabolic disruptions are early contributors to endothelial dysfunction, a primary feature of diabetic vascular complications, such as retinopathy, impaired wound healing and cerebral small vessel disease. The degree to which metabolism varies amongst such different vascular beds is unknown. Mitochondrial function was therefore characterised in human aortic, dermal, retinal and cerebral ECs in vitro, aiming to determine whether basal metabolism influences the response and susceptibility of vascular beds experimental hyperglycaemia (HG). Furthermore, the potential of metformin to maintain endothelial function independent of glycaemic control was assessed. Using a Seahorse analyser, metabolic function of human primary ECs from different vascular beds was compared under basal conditions, as well as HG and metformin treatment. ECs differed significantly in respiratory profile and glycolytic function. For example aortic ECs were preferentially aerobic, whereas dermal ECs were glycolytic. HG significantly lowered mitochondrial network area but elicited modest effects upon respiratory function at the same time as influencing glycolytic function in a manner that was possibly conditional upon basal utilisation. Metformin inhibited basal respiratory function at the same time as significantly enhancing glycolysis in retinal and brain ECs. These data suggest that EC responses to HG and metformin are influenced by the basal metabolic profile, highlighting the potential of targeting EC metabolism to preserve function in a diabetic condition. A nuanced approach is needed to address diabetic vascular complications and endothelial metabolic health in diabetes, both in the investigation of pathophysiology and in prospective therapeutics.

Item Type: Articles
Additional Information: Corey McAleese is a recipient of a British Heart Foundation 4-year studentship (FS/4yPHD/F/20/34127). Laura Bethany Dowsett is supported by a BHF Project Grant (PG/21/10531). Ghadeer Joudah was supported by a Scholarship from King Abdulaziz University KSA/ MOE| Saudi Arabian Cultural Mission
Status: Early Online Publication
Refereed: Yes
Glasgow Author(s) Enlighten ID: McAleese, Mr Corey and Dowsett, Dr Laura and Salt, Dr Ian and Joudah, Ghadeer Adel M and Leiper, Professor James and Petrie, Professor John
Authors: McAleese, C., Joudah, G., Salt, I.P., Petrie, J.R., Leiper, J.M., and Dowsett, L. B.
College/School: College of Medical Veterinary and Life SciencesCollege of Medical Veterinary and Life Sciences > School of Cancer SciencesCollege of Medical Veterinary and Life Sciences > School of Cardiovascular & Metabolic Health
Journal Name: Journal of Physiology
Publisher: Wiley
ISSN: 0022-3751
ISSN (Online): 1469-7793
Published Online: 25 February 2025
Copyright Holders: Copyright © 2025 The Authors
First Published: First published in Journal of Physiology 2025
Publisher Policy: Reproduced under a Creative Commons licence

University Staff: Request a correction | Enlighten Editors: Update this record

Funder and Project Information

BHF 4Yr PhD Studentship Award 2020

Rhian Touyz

FS/4yPhD/F/20/34127

SCMH - Cardiovascular & Metabolic Health

Asymmetric dimethylarginine signalling via the calcium sensing receptor in the vascular and metabolic complications of type 2 diabetes

Laura Dowsett

PG/21/10531

SCMH - Cardiovascular & Metabolic Health

Deposit and Record Details

ID Code: 348024
Depositing User: Ms Gail Annan
Datestamp: 05 Mar 2025 09:14
Last Modified: 17 Apr 2025 14:24
Date of acceptance: 7 February 2025
Date of first online publication: 25 February 2025
Date Deposited: 5 March 2025
Data Availability Statement: Yes